These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33728295)

  • 21. Clinical characteristics of coronavirus disease 2019 in Gansu province, China.
    Yue H; Bai X; Wang J; Yu Q; Liu W; Pu J; Wang X; Hu J; Xu D; Li X; Kang N; Li L; Lu W; Feng T; Ding L; Li X; Qi X;
    Ann Palliat Med; 2020 Jul; 9(4):1404-1412. PubMed ID: 32692208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and immunological features of severe and moderate coronavirus disease 2019.
    Chen G; Wu D; Guo W; Cao Y; Huang D; Wang H; Wang T; Zhang X; Chen H; Yu H; Zhang X; Zhang M; Wu S; Song J; Chen T; Han M; Li S; Luo X; Zhao J; Ning Q
    J Clin Invest; 2020 May; 130(5):2620-2629. PubMed ID: 32217835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the SARS-CoV-2 Receptor ACE2 and Proinflammatory Cytokines Induced by the Periodontopathic Bacterium
    Takahashi Y; Watanabe N; Kamio N; Yokoe S; Suzuki R; Sato S; Iinuma T; Imai K
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
    Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
    Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: A systematic review and meta-analysis.
    Mahat RK; Panda S; Rathore V; Swain S; Yadav L; Sah SP
    Clin Epidemiol Glob Health; 2021; 11():100727. PubMed ID: 33778183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 and the human innate immune system.
    Schultze JL; Aschenbrenner AC
    Cell; 2021 Apr; 184(7):1671-1692. PubMed ID: 33743212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
    Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
    Front Immunol; 2021; 12():629193. PubMed ID: 33732251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm.
    Zimecki M; Actor JK; Kruzel ML
    Int Immunopharmacol; 2021 Jun; 95():107571. PubMed ID: 33765614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19.
    Delshad M; Tavakolinia N; Pourbagheri-Sigaroodi A; Safaroghli-Azar A; Bagheri N; Bashash D
    Int Immunopharmacol; 2021 Jun; 95():107586. PubMed ID: 33765611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The most important biomarker associated with coagulation and inflammation among COVID-19 patients.
    Hong LZ; Shou ZX; Zheng DM; Jin X
    Mol Cell Biochem; 2021 Jul; 476(7):2877-2885. PubMed ID: 33742367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
    Ravindra NG; Alfajaro MM; Gasque V; Huston NC; Wan H; Szigeti-Buck K; Yasumoto Y; Greaney AM; Habet V; Chow RD; Chen JS; Wei J; Filler RB; Wang B; Wang G; Niklason LE; Montgomery RR; Eisenbarth SC; Chen S; Williams A; Iwasaki A; Horvath TL; Foxman EF; Pierce RW; Pyle AM; van Dijk D; Wilen CB
    PLoS Biol; 2021 Mar; 19(3):e3001143. PubMed ID: 33730024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smell recovery in patients with COVID-19: an experience with nebulized nasal treatment.
    Varricchio A; La Mantia I; Brunese FP; Ciprandi G
    J Biol Regul Homeost Agents; 2021; 35(2):683-686. PubMed ID: 33728831
    [No Abstract]   [Full Text] [Related]  

  • 34. The role and delicate balance of Host Immunity in Coronavirus Disease-19.
    Vyas AK; Varma V; Garg G; Gupta P; Trehanpati N
    Iran J Immunol; 2021 Mar; 18(1):1-12. PubMed ID: 33787510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronavirus infection: An immunologists' perspective.
    De Sanctis JB; García AH; Moreno D; Hajduch M
    Scand J Immunol; 2021 Jun; 93(6):e13043. PubMed ID: 33783027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of some potential immunotherapeutic options against COVID-19.
    Bayat M; Asemani Y; Mohammadi MR; Sanaei M; Namvarpour M; Eftekhari R
    Int Immunopharmacol; 2021 Jun; 95():107516. PubMed ID: 33765610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019.
    Gao F; Zheng KI; Yan HD; Sun QF; Pan KH; Wang TY; Chen YP; Targher G; Byrne CD; George J; Zheng MH
    Front Endocrinol (Lausanne); 2021; 12():604100. PubMed ID: 33763027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and neurophysiological characterization of muscular weakness in severe COVID-19.
    Bax F; Lettieri C; Marini A; Pellitteri G; Surcinelli A; Valente M; Budai R; Patruno V; Gigli GL
    Neurol Sci; 2021 Jun; 42(6):2173-2178. PubMed ID: 33755815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-acute COVID-19 syndrome.
    Nalbandian A; Sehgal K; Gupta A; Madhavan MV; McGroder C; Stevens JS; Cook JR; Nordvig AS; Shalev D; Sehrawat TS; Ahluwalia N; Bikdeli B; Dietz D; Der-Nigoghossian C; Liyanage-Don N; Rosner GF; Bernstein EJ; Mohan S; Beckley AA; Seres DS; Choueiri TK; Uriel N; Ausiello JC; Accili D; Freedberg DE; Baldwin M; Schwartz A; Brodie D; Garcia CK; Elkind MSV; Connors JM; Bilezikian JP; Landry DW; Wan EY
    Nat Med; 2021 Apr; 27(4):601-615. PubMed ID: 33753937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19.
    Wu J; Liang B; Chen C; Wang H; Fang Y; Shen S; Yang X; Wang B; Chen L; Chen Q; Wu Y; Liu J; Yang X; Li W; Zhu B; Zhou W; Wang H; Li S; Lu S; Liu D; Li H; Krawczyk A; Lu M; Yang D; Deng F; Dittmer U; Trilling M; Zheng X
    Nat Commun; 2021 Mar; 12(1):1813. PubMed ID: 33753738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.